About ASLAN Pharmaceuticals
ASLAN Pharmaceuticals is a company based in Singapore (Singapore) founded in 2010.. ASLAN Pharmaceuticals has raised $100 million across 9 funding rounds from investors including Haitong International Securities Group, Tianda Pharmaceutical and K2 HealthVentures. ASLAN Pharmaceuticals operates in a competitive market with competitors including UNION Therapeutics, Concerto Biosciences, Biosion, Forte Biosciences and PinCell, among others.
- Headquarter Singapore, Singapore
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aslan Pharmaceuticals Pte Ltd
-
Annual Revenue
-
Net Profit
$-46.34 M-55as on Dec 31, 2022
-
EBITDA
$-45.89 M-57as on Dec 31, 2022
-
Total Equity Funding
$100 M (USD)
in 9 rounds
-
Latest Funding Round
$20 M (USD), Post-IPO
Mar 02, 2023
-
Investors
Haitong International Securities Group
& 13 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of ASLAN Pharmaceuticals
ASLAN Pharmaceuticals has successfully raised a total of $100M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $20.0M
- First Round First Round
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Post-IPO - ASLAN Pharmaceuticals | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - ASLAN Pharmaceuticals | Valuation |
investors |
|
| Oct, 2019 | Amount | Debt – Conventional - ASLAN Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ASLAN Pharmaceuticals
ASLAN Pharmaceuticals has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Haitong International Securities Group, Tianda Pharmaceutical and K2 HealthVentures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Flexible, long-term financing solutions are provided to healthcare companies.
|
Founded Year | Domain | Location | |
|
US private equity investments are managed by BVF Partners.
|
Founded Year | Domain | Location | |
|
Venture capital investments are managed by Top Taiwan.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ASLAN Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ASLAN Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aslan Pharmaceuticals Comparisons
Competitors of ASLAN Pharmaceuticals
ASLAN Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as UNION Therapeutics, Concerto Biosciences, Biosion, Forte Biosciences and PinCell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule antibiotics are developed for bacterial infections.
|
|
| domain | founded_year | HQ Location |
Microbe-based products are developed for agriculture and human health.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for inflammatory skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of anti-inflammatory therapy for the treatment skin diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aslan Pharmaceuticals
Frequently Asked Questions about ASLAN Pharmaceuticals
When was ASLAN Pharmaceuticals founded?
ASLAN Pharmaceuticals was founded in 2010.
Where is ASLAN Pharmaceuticals located?
ASLAN Pharmaceuticals is headquartered in Singapore, Singapore.
Is ASLAN Pharmaceuticals a funded company?
ASLAN Pharmaceuticals is a funded company, having raised a total of $100M across 9 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $3M, raised on Jul 27, 2010.
What does ASLAN Pharmaceuticals do?
ASLAN Pharmaceuticals was founded in 2010 in Singapore as an oncology-focused entity. Targeted drugs are developed for gastric, bile duct, and breast cancers through a proprietary pipeline of four candidates. These address indications including gastric and breast cancers plus inflammatory diseases. ASLAN001, a pan-HER inhibitor, advances in phase 2 for gastric cancer and extends to cholangiocarcinoma and breast cancer. ASLAN002 targets RON and cMET receptors for gastric and breast applications.
Who are the top competitors of ASLAN Pharmaceuticals?
ASLAN Pharmaceuticals's top competitors include Concerto Biosciences, UNION Therapeutics and Biosion.
Who are ASLAN Pharmaceuticals's investors?
ASLAN Pharmaceuticals has 14 investors. Key investors include Haitong International Securities Group, Tianda Pharmaceutical, K2 HealthVentures, BVF Partners, and Top Taiwan.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.